IO Biotech (NASDAQ:IOBT) just reported results for the first quarter of 2024.
- IO Biotech reported earnings per share of -30 cents. This was above the analyst estimate for EPS of -36 cents.
- The company did not report any revenue for the quarter.
Source: iQoncept / Shutterstock
IO Biotech (NASDAQ:IOBT) just reported results for the first quarter of 2024.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/iobt-stock-earnings-io-biotech-for-q1-of-2024/.
©2025 InvestorPlace Media, LLC